Literature DB >> 2121159

Interleukins and tumor necrosis factor in inflammation.

J S Warren1.   

Abstract

Intense research efforts have been directed toward characterizing mediators that control the inflammatory response and regulate the growth, differentiation, and function of cells involved in inflammation. Tumor necrosis factor, or cachectin, and members of a heterogeneous group of peptides called interleukins exhibit a wide spectrum of activities, some of which appear to influence the evolution of inflammatory processes. This review outlines the observations that have led to our current understanding of the biology of tumor necrosis factor and the interleukins. Particular attention is directed toward the evidence suggesting that these cytokines function as mediators of inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2121159     DOI: 10.3109/10408369009105897

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  22 in total

1.  Genetic variability of inflammatory genes in the Brazilian population.

Authors:  Marcelo dos Santos; Elaine Stur; Lucas Lima Maia; Lidiane Pignaton Agostini; Gabriela Tonini Peterle; Suzanny Oliveira Mendes; Eloiza Helena Tajara; Marcos Brasilino de Carvalho; Iúri Drumond Louro; Adriana Madeira Álvares Silva-Conforti
Journal:  Genet Test Mol Biomarkers       Date:  2013-08-03

Review 2.  Micronutrients and immune function: some recent developments.

Authors:  D I Thurnham
Journal:  J Clin Pathol       Date:  1997-11       Impact factor: 3.411

3.  Pro-inflammatory cytokine expression studies of subclinical and clinical endometritis in endometrial tissues of buffaloes.

Authors:  A R Bhadaniya; M C Prasad; H H Savsani; V A Kalaria; D T Fefar; B S Mathpati; B B Javia
Journal:  Trop Anim Health Prod       Date:  2019-01-25       Impact factor: 1.559

4.  Amelioration of oxidative and inflammatory changes by Swertia chirayita leaves in experimental arthritis.

Authors:  Harsha Lad; Deepak Bhatnagar
Journal:  Inflammopharmacology       Date:  2016-10-14       Impact factor: 4.473

5.  MiR-19a mediates the negative regulation of the NF-κB pathway in lipopolysaccharide-induced endometritis by targeting TBK1.

Authors:  Nannan Yin; Yaping Yang; Xiaoyan Wang; Chao Yang; Xiaofei Ma; Aftab Shaukat; Gan Zhao; Ganzhen Deng
Journal:  Inflamm Res       Date:  2019-01-23       Impact factor: 4.575

6.  A benzamide-linked small molecule NDMC101 inhibits NFATc1 and NF-κB activity: a potential osteoclastogenesis inhibitor for experimental arthritis.

Authors:  Chia-Pi Cheng; Hsu-Shan Huang; Yu-Chieh Hsu; Ming-Jen Sheu; Deh-Ming Chang
Journal:  J Clin Immunol       Date:  2012-02-23       Impact factor: 8.317

7.  Play and players in bone fracture healing match.

Authors:  Lorenzo Marzona; Bernardo Pavolini
Journal:  Clin Cases Miner Bone Metab       Date:  2009-05

8.  Effects of pyridinyl imidazole compounds on murine TNF-alpha production.

Authors:  D L Olivera; J T Laydon; L Hillegass; A M Badger; J C Lee
Journal:  Agents Actions       Date:  1993

9.  Effect and mechanism of AR-6 in experimental rheumatoid arthritis.

Authors:  Shi-xue Sun; Yun-man Li; Wei-rong Fang; Peng Cheng; Lifang Liu; Fengwen Li
Journal:  Clin Exp Med       Date:  2009-10-20       Impact factor: 3.984

10.  The effect of thalidomide on vascular endothelial growth factor and tumor necrosis factor-alpha levels in retinal ischemia/reperfusion injury.

Authors:  Semih Aydoğan; Ulkü Celiker; Peykan Türkçüoğlu; Nevin Ilhan; Nusret Akpolat
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-09-03       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.